Literature DB >> 31519551

Dietary Phosphorus and FGF23: Is More Restriction Better?

Kathleen M Hill Gallant1,2.   

Abstract

Entities:  

Keywords:  dialysis; hyperphosphatemia; nutrition

Year:  2019        PMID: 31519551      PMCID: PMC6777604          DOI: 10.2215/CJN.09640819

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.

Authors:  Wan-Chuan Tsai; Ju-Yeh Yang; Chia-Chin Luan; Yuh-Jiun Wang; Yu-Chuan Lai; Lie-Chuan Liu; Yu-Sen Peng
Journal:  Clin Exp Nephrol       Date:  2015-12-11       Impact factor: 2.801

3.  Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Authors:  Sharon M Moe; Miriam P Zidehsarai; Mary A Chambers; Lisa A Jackman; J Scott Radcliffe; Laurie L Trevino; Susan E Donahue; John R Asplin
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 8.237

4.  KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2017-06-21

Review 5.  Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

Authors:  Tamara Isakova; Joachim H Ix; Stuart M Sprague; Kalani L Raphael; Linda Fried; Jennifer J Gassman; Dominic Raj; Alfred K Cheung; John W Kusek; Michael F Flessner; Myles Wolf; Geoffrey A Block
Journal:  J Am Soc Nephrol       Date:  2015-05-12       Impact factor: 10.121

6.  Short-Term Effects of Very-Low-Phosphate and Low-Phosphate Diets on Fibroblast Growth Factor 23 in Hemodialysis Patients: A Randomized Crossover Trial.

Authors:  Wan-Chuan Tsai; Hon-Yen Wu; Yu-Sen Peng; Shih-Ping Hsu; Yen-Ling Chiu; Ju-Yeh Yang; Hung-Yuan Chen; Mei-Fen Pai; Wan-Yu Lin; Kuan-Yu Hung; Fang-Yeh Chu; Shu-Min Tsai; Kuo-Liong Chien
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-13       Impact factor: 8.237

Review 7.  Assessing the health impact of phosphorus in the food supply: issues and considerations.

Authors:  Mona S Calvo; Alanna J Moshfegh; Katherine L Tucker
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

Review 8.  Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action.

Authors:  Mona S Calvo; Richard A Sherman; Jaime Uribarri
Journal:  Am J Kidney Dis       Date:  2019-01-25       Impact factor: 8.860

Review 9.  Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism.

Authors:  Brandon M Kistler; Debbie Benner; Jerrilynn D Burrowes; Katrina L Campbell; Denis Fouque; Giacomo Garibotto; Joel D Kopple; Csaba P Kovesdy; Connie M Rhee; Alison Steiber; Peter Stenvinkel; Pieter Ter Wee; Daniel Teta; Angela Y M Wang; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2018-01       Impact factor: 3.655

10.  Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets.

Authors:  Wan-Chuan Tsai; Yu-Sen Peng; Hon-Yen Wu; Shih-Ping Hsu; Yen-Ling Chiu; Lie-Chuan Liu; Shu-Min Tsai; Kuo-Liong Chien
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

  10 in total
  1 in total

1.  Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial.

Authors:  Wan-Chuan Tsai; Hon-Yen Wu; Yen-Ling Chiu; Ju-Yeh Yang; Mei-Fen Pai; Yong-Ru Wu; Wan-Yu Lin; Kuan-Yu Hung; Kuo-Liong Chien; Shih-Ping Hsu; Yu-Sen Peng
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.